CRVO
Price
$12.29
Change
-$0.18 (-1.44%)
Updated
Nov 5, 04:00 PM (EDT)
VIRX
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
Ad is loading...

CRVO vs VIRX

Header iconCRVO vs VIRX Comparison
Open Charts CRVO vs VIRXBanner chart's image
CervoMed
Price$12.29
Change-$0.18 (-1.44%)
Volume$6.09K
CapitalizationN/A
Viracta Therapeutics
Price$0.20
Change-$0.00 (-0.00%)
Volume$37.94K
CapitalizationN/A
View a ticker or compare two or three
CRVO vs VIRX Comparison Chart
Loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRVO vs. VIRX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVO is a Buy and VIRX is a StrongSell.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (CRVO: $12.55 vs. VIRX: $0.20)
Brand notoriety: CRVO and VIRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVO: 68% vs. VIRX: 45%
Market capitalization -- CRVO: $103.58M vs. VIRX: $8M
CRVO [@Biotechnology] is valued at $103.58M. VIRX’s [@Biotechnology] market capitalization is $8M. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVO’s FA Score shows that 0 FA rating(s) are green whileVIRX’s FA Score has 1 green FA rating(s).

  • CRVO’s FA Score: 0 green, 5 red.
  • VIRX’s FA Score: 1 green, 4 red.
According to our system of comparison, CRVO is a better buy in the long-term than VIRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVO’s TA Score shows that 4 TA indicator(s) are bullish while VIRX’s TA Score has 2 bullish TA indicator(s).

  • CRVO’s TA Score: 4 bullish, 3 bearish.
  • VIRX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CRVO is a better buy in the short-term than VIRX.

Price Growth

CRVO (@Biotechnology) experienced а -4.27% price change this week, while VIRX (@Biotechnology) price change was -12.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

CRVO is expected to report earnings on Nov 13, 2023.

VIRX is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRVO($104M) has a higher market cap than VIRX($8M). CRVO YTD gains are higher at: 64.482 vs. VIRX (-64.412). CRVO has higher annual earnings (EBITDA): -5.1M vs. VIRX (-41.42M). CRVO has more cash in the bank: 45.1M vs. VIRX (30M). CRVO has less debt than VIRX: CRVO (0) vs VIRX (18.8M). CRVO (0) and VIRX (0) have equivalent revenues.
CRVOVIRXCRVO / VIRX
Capitalization104M8M1,301%
EBITDA-5.1M-41.42M12%
Gain YTD64.482-64.412-100%
P/E Ratio5.43N/A-
Revenue00-
Total Cash45.1M30M150%
Total Debt018.8M-
FUNDAMENTALS RATINGS
CRVO vs VIRX: Fundamental Ratings
CRVO
VIRX
OUTLOOK RATING
1..100
950
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
5695
P/E GROWTH RATING
1..100
6116
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (45) in the Biotechnology industry is in the same range as VIRX (69). This means that CRVO’s stock grew similarly to VIRX’s over the last 12 months.

CRVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VIRX (100). This means that CRVO’s stock grew similarly to VIRX’s over the last 12 months.

CRVO's SMR Rating (93) in the Biotechnology industry is in the same range as VIRX (99). This means that CRVO’s stock grew similarly to VIRX’s over the last 12 months.

CRVO's Price Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for VIRX (95). This means that CRVO’s stock grew somewhat faster than VIRX’s over the last 12 months.

VIRX's P/E Growth Rating (16) in the Biotechnology industry is somewhat better than the same rating for CRVO (61). This means that VIRX’s stock grew somewhat faster than CRVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVOVIRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VIRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNEFF2.480.10
+4.20%
Bonterra Energy Corp.
REPYY12.820.25
+1.99%
Repsol S.A.
SRNW0.14N/A
+0.14%
Stratos Renewables Corp.
DASTF34.81N/A
N/A
Dassault Systemes SA
ORKLY9.39-0.02
-0.21%
Orkla ASA

CRVO and

Correlation & Price change

A.I.dvisor tells us that CRVO and VIRX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRVO and VIRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
-2.03%
VIRX - CRVO
28%
Poorly correlated
+4.35%
VKTX - CRVO
27%
Poorly correlated
-13.37%
NKTR - CRVO
27%
Poorly correlated
+8.94%
AVXL - CRVO
27%
Poorly correlated
+6.66%
FATE - CRVO
25%
Poorly correlated
+13.58%
More

VIRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIRX has been loosely correlated with MDGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VIRX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIRX
1D Price
Change %
VIRX100%
+4.35%
MDGL - VIRX
38%
Loosely correlated
+3.67%
CHRS - VIRX
34%
Loosely correlated
-7.33%
MRNS - VIRX
31%
Poorly correlated
+2.20%
AXON - VIRX
30%
Poorly correlated
+1.35%
CYTK - VIRX
30%
Poorly correlated
-0.66%
More